During the last session, P3 Health Partners Inc (NASDAQ:PIII)’s traded shares were 7.12 million, with the beta value of the company hitting 0.94. At the end of the trading day, the stock’s price was $0.24, reflecting an intraday gain of 17.73% or $0.04. The 52-week high for the PIII share is $1.22, that puts it down -408.33 from that peak though still a striking 29.17% gain since the share price plummeted to a 52-week low of $0.17. The company’s market capitalization is $85.76M, and the average trade volume was 2.22 million shares over the past three months.
P3 Health Partners Inc (PIII) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.80. PIII has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.09.
P3 Health Partners Inc (NASDAQ:PIII) trade information
P3 Health Partners Inc (PIII) registered a 17.73% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 17.73% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is 17.62%, and it has moved by 5.29% in 30 days. Based on these gigs, the overall price performance for the year is -77.45%.
P3 Health Partners Inc (PIII) estimates and forecasts
In the rating firms’ projections, revenue will increase 19.13% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 378.88M as predicted by 4 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 375.8M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 346.86M and 388.49M respectively. In this case, analysts expect current quarter sales to grow by 9.23% and then drop by -3.27% in the coming quarter.
While earnings are projected to return 11.11% in 2025, the next five years will return 12.64% per annum.
PIII Dividends
P3 Health Partners Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 7.9 million shares, is of ARMISTICE CAPITAL, LLC’s that is approximately 6.645% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.56 million.
